SureTrader SPDR Advertisement SPDR Advertisement
Home > Boards > US Listed > Biotechs >

Inovio Pharmaceuticals, Inc. (INO)

Add INO Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator biovalidator
Search This Board:
Last Post: 7/29/2015 1:09:02 PM - Followers: 392 - Board type: Free - Posts Today: 0

Logo: Inovio

ebruary 12, 2014 Inovio CEO Dr. Joseph Kim rings bell to open trading on NYSE-

Float: 97.65 M

Shares Outstanding: 127.26 M

Inovio Biomedical Corporation engages in the design, development, and delivery of a new generation of vaccines, called DNA vaccines, focused on cancers and infectious diseases. The company?s SynCon technology enables the design of DNA-based vaccines capable of providing cross-protection against evolving, unmatched strains of pathogens, such as influenza. Inovio?s proprietary electroporation DNA delivery technology uses brief, controlled electrical pulses to increase cellular DNA vaccine uptake. The company also has access to formulation and manufacturing expertise, and technology through its controlling ownership in VGX International. Inovio?s clinical programs include trials for HPV/cervical cancer (therapeutic) and HIV vaccines; and an IND has been filed for an avian influenza vaccine. Its partners and collaborators include Roche,Merck, Tripep, University of Southampton, University of Pennsylvania, HIV Vaccines Trial Network, and National Microbiology Laboratory of the Public Health Agency of Canada. The company was formerly known as Genetronics Biomedical Corp. and changed its name to Inovio Biomedical Corporation in March 2005. The company was founded in 1983 and is based in San Diego, California.

Currently Inovio has 12 clinical studies ( HIV, Influenza, Malaria, Hepatitis B, Hepatitis C, Breast and Lung cancer, Prostate Cancer, Head and Neck cancer, Cervical Cancer, Cervical dysplasia caused by HPV) ongoing from preclinical to phase 2.
Sep 10, 2013
Roche and Inovio Pharmaceuticals partner on Inovio's prostate cancer and hepatitis B immunotherapy products. Roche will make an upfront payment of USD $10 million to Inovio. Roche will also provide preclinical R&D support and payments for near-term regulatory milestones as well as payments upon reaching certain development and commercial milestones potentially up to USD $412.5 million. Additional development milestone payments could also be made to Inovio if Roche pursues other indications with INO-5150 or INO-1800.  In addition, Inovio is entitled to receive up to double-digit tiered royalties on product sales.

VGX-3100-Phase 2 Clinical Trial initiated for the treatment Cervical dysplasia (cervical intraepithelial neoplasia or CIN) caused by HPV
Top line data release Mid 2014
May 13, 2014:  Inovio Pharmaceuticals Acquires Early Stage DNA Therapies to Treat Alzheimer's and Multiple Sclerosis

May 23, 2014: Inovio Pharmaceuticals Announces 1 For 4 Reverse Split
1-for-4 reverse stock split shall become effective at 5 P.M., Thursday, June 5, 2014, and trading of the Company's common stock on a post-reverse split basis shall commence on Friday, June 6, 2014.

Inovio’s goal is to revolutionize vaccines. With best-in-class immune responses from multiple vaccines in different disease areas, our synthetic vaccine technology is making big strides toward this important goal.



  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
#4698  Sticky Note Please stay on topic. The only topic to IH Admin [Dan] 08/02/13 01:15:33 PM
#13030   Cancer, influenza, bacteria and viruses don't stand a chance! nanopatent 07/29/15 01:09:02 PM
#13029   Inovio Pharmaceuticals’ DNA-Based Monoclonal Antibody Protects Animals Against nanopatent 07/29/15 01:07:51 PM
#13028   Second Quarter 2015 Financial Results August 10, 2015 biovalidator 07/19/15 08:02:54 PM
#13027   gee I hope they got more than ONCS dr_lowenstein 07/16/15 01:42:39 PM
#13026   Bio, Remember the ONCS warrants would automatically adjust someconcerns 07/15/15 06:27:42 PM
#13025   Dr Kim was still a young and inexperienced TomP1 07/15/15 09:20:35 AM
#13023   does anyone know why INO off loaded tech dr_lowenstein 07/11/15 07:25:52 PM
#13022   Interesting Upcoming combo therapy presentation by Dr. Bagarazzi biovalidator 07/11/15 10:31:50 AM
#13021   Waiting game here. Added more at these prices, harry crumb 07/10/15 02:26:52 PM
#13020   All sectors got crushed, not just bio's. Oppertunity harry crumb 07/08/15 04:44:30 PM
#13013   INO Favored? nanopatent 06/30/15 09:49:07 PM
#13012   INO I see from a prior post, INO MiamiGent 06/30/15 07:20:00 PM
#13011   Same to your other buddy/persona Ankin Perkin78 06/30/15 11:58:45 AM
#13010   This is an INO Board. Quit peddling other Perkin78 06/30/15 11:57:07 AM
#13007   Don't worry. We've all been through this rodeo before. Peterconway13 06/29/15 10:59:27 PM
#13006   Another down day for INO. What is going blgsmartsta 06/29/15 07:04:26 PM
#13004   Nice gap close today anflipped in an out harry crumb 06/26/15 04:52:50 PM
#13003   Seems like another down day of investments for blgsmartsta 06/26/15 02:34:52 PM
#13002   Seems like the market is down. Hopefully picks blgsmartsta 06/25/15 03:39:22 PM
#12999   $INO IS A GOOOOOOOOO! DanClark69 06/22/15 02:10:09 PM
#12998   $INO IS A GOOOOOOOOO! JUMP IN NOW! DanClark69 06/22/15 02:03:12 PM
#12997   INOVIO PIPELINE LINK DanClark69 06/21/15 09:12:20 PM
#12996   Pipeline looks Great! Up the Inovians! MRatt 06/21/15 09:42:54 AM
#12995   $31 a share coming LOOK AT THE PIPELINE!! DanClark69 06/20/15 10:14:31 AM
#12994   Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Price Target Update nanopatent 06/19/15 09:39:24 AM
#12993   Why is it so quiet here ??! SABAI 06/18/15 12:52:07 PM
#12992   I guess they're doing this. I'm in South Lebowsky 06/16/15 12:42:22 PM
#12991   Does anyone know what happened to the MERS Sunnyjoe234 06/14/15 08:27:49 PM
#12990   Inovio Pharmaceuticals CEO Named "Entrepreneur of the Year" nanopatent 06/12/15 01:55:04 PM
#12989   Why Inovio Pharmaceuticals (INO) Could Be Positioned for nanopatent 06/11/15 10:01:53 AM
#12988   So much upwards room, ino could be huge harry crumb 06/11/15 10:00:41 AM
#12987   People don't appreciate the value in a "Netflix" nanopatent 06/10/15 12:50:14 PM
#12986   I wonder why this isnt much higher now. SABAI 06/10/15 12:21:57 PM
#12985   Inovio Pharmaceuticals, Inc. Analyst Rating Update nanopatent 06/09/15 10:10:04 AM
#12984   Homers DNA vaccines Good to see Homer J. nanopatent 06/09/15 10:03:07 AM
#12983   News for INO and partner on Ebola and biovalidator 06/09/15 08:51:59 AM
#12982   Lebowsky: source is right there in my post. Rogerthat1 06/08/15 04:33:40 PM
#12981   $30 is a good starting point when the nanopatent 06/08/15 02:32:29 PM
#12980   MARKET REPORT: Healthy interest in Inovio Pharmaceuticals's future nanopatent 06/08/15 02:28:08 PM
#12979   I gave you the source. Check there. Rogerthat1 06/08/15 01:57:17 PM
#12978   Somebody knows something or is a class A bullshitter. nanopatent 06/08/15 01:55:00 PM
#12977   Doesnt look like but where there is smoke... Rogerthat1 06/08/15 01:51:59 PM
#12976   Encouraging! nanopatent 06/08/15 01:46:14 PM
#12975   Don't think Kim would anyways. Rogerthat1 06/08/15 09:53:19 AM
#12974   Don't sell! nanopatent 06/08/15 09:47:17 AM
#12973   $INO buyout potential news!!! Rogerthat1 06/07/15 02:08:23 PM
#12972   Wwweeeeee harry crumb 06/04/15 12:53:42 PM
#12971   100, you mean! nanopatent 06/04/15 12:38:17 PM
#12970   Ino moving again, over 10 is coming. harry crumb 06/04/15 12:08:22 PM
#12969 MRatt 06/03/15 01:00:44 PM